BCAX - Bicara Corp Revenue Growth YoY (Last 12 Months)

Brandmark of bicara.com (BCAX)

Anticipation of the start of large-scale Phase 3 trials for head and neck cancer therapy serves as the key driver for Bicara Therapeutics Inc. (BCAX). The current sales growth rate over a rolling 12-month period year-over-year illustrates revenue dynamics, where the 0.00 level records fresh values. However, success depends on new capital infusions and early trial outcomes, while numerous developers of targeted drugs create pressure.

BCAX Bicara Therapeutics Inc: Sales Growth YoY (Last Twelve Months) in the range 11/23/2025 - 11/18/2026

Bicara Therapeutics - analytical breakdowns and key metrics (BCAX)

- stock value and consensus price forecast:
Fundamental company valuation:Bicara Bio BCAX
Original product of bicara.com

Bicara Therapeutics Inc. (BCAX) development in the oncology therapy segment via bifunctional antibodies is reflected in the TTM revenue growth trajectory compared to last year. This metric calculates the percentage change in total sales over a rolling 12-month period relative to the same period last year, allowing investors to filter out volatility and assess the real commercialization dynamics of patent-protected innovative products.

Who Bicara Therapeutics Inc. competes with

Annual Revenue Growth (Last Twelve Months) BeiGene Corp (ONC)|HALO - Sales Growth YoY (Last Twelve Months)|RVMD: Sales Growth YoY (Last Twelve Months)|AAPG: Sales Growth YoY (TTM)|Trailing Twelve Months Revenue Growth CG Oncology Inc (CGON)|URGN (urogen.com) - Sales Growth YoY (TTM)|Trailing Twelve Months Revenue Growth Personalis Genomics PSNL|Sales Growth YoY (TTM) ERAS|Revenue Change YoY (Last 12 Months) DCTH|Y-mAbs Therapeutics, Inc. - Revenue Growth YoY (Last 12 Months)|Annual Revenue Growth (Last Twelve Months) Aura Biosciences Inc (AURA)|CADL: Revenue Growth YoY (Last 12 Months)|Revenue Dynamics YoY (Last Twelve Months) ARAY (Accuray Inc.)|SLS: Sales Growth YoY (TTM)|ACTU: Revenue Change YoY (Last 12 Months)|CTOR (Citius Oncology Inc.) - Sales Growth YoY (TTM)|Trailing Twelve Months Revenue Growth tuhurabio.com HURA|Sales Growth YoY (TTM) TARA|FATE: Trailing Twelve Months Sales Growth|Sales Growth YoY (TTM) WHWK (Aadi Bioscience)|TCRX (TScan) - Trailing Twelve Months Sales Growth|Champions Oncology, Inc. - Sales Growth YoY (TTM)|Annual Revenue Growth (Last Twelve Months) XBiotech Inc XBIT|CVM: Sales Growth YoY (TTM)|OSTX - Annual Revenue Growth (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) Radiopharm Theranostics Limited|Sales Growth YoY (TTM) artivabio.com|Revenue Growth YoY (Last 12 Months) ANL (Adlai Nortye Limited)|Veru - Sales Growth YoY (Last 12 Months)|Tempest Therapeutics, Inc. - Revenue Growth YoY (Last 12 Months)|Annual Revenue Growth (Last Twelve Months) xiliotx.com (XLO)|Renovaro - Sales Growth YoY (TTM)|Mural Oncology (MURA) - Revenue Growth YoY (Last 12 Months)|KAPA: Sales Growth YoY (TTM)|OKUR - Annual Revenue Growth (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) CytoMed Therapeutics Limited|CRIS: Revenue Dynamics YoY (Last Twelve Months)|Sales Growth YoY (TTM) APLM|Sales Growth YoY (TTM) tharimmune.com (THAR)|Advanced Biomed Corp - Revenue Growth YoY (Last 12 Months)|Revenue Dynamics YoY (Last Twelve Months) GNPX|Calidi Biotherapeutics, Inc. - Sales Growth YoY (TTM)|Sunshine Biopharma (SBFM) - Revenue Growth YoY (Last 12 Months)|XBIO: Sales Growth YoY (TTM)|SLRX - Annual Revenue Growth (Last Twelve Months)|Revenue Growth YoY (Last 12 Months) PPBT|Sales Growth YoY (TTM) American Oncology Network|Sales Growth YoY (Last Twelve Months) BeOne Medicines (BGNE)|CKPT: Trailing Twelve Months Sales Growth|Sales Growth YoY (TTM) ELEV (Elevation Oncology Inc.)|Sales Growth YoY (TTM) iCAD Corp ICAD|Ikena - Sales Growth YoY (TTM)|Revenue Dynamics YoY (Last Twelve Months) NTBL (Notable Labs)|VIRX: Sales Growth YoY (TTM)|Trailing Twelve Months Sales Growth MOR (MorphoSys Corp)|Sales Growth YoY (Last Twelve Months) NAYA Biosciences|Sales Growth YoY (TTM) ascentage.com